United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 416,000 | 244,800 | 137,700 | -104,500 | -157,100 |
| Depreciation Amortization | 36,800 | 25,000 | 12,400 | 45,900 | 33,400 |
| Accounts receivable | -900 | -20,600 | 1,700 | 24,400 | -7,800 |
| Accounts payable and accrued liabilities | 27,900 | 2,600 | -18,800 | -16,300 | -4,900 |
| Other Working Capital | 102,400 | 35,700 | 52,900 | -178,300 | -192,600 |
| Other Operating Activity | 47,300 | 91,100 | 28,700 | 22,200 | 19,900 |
| Operating Cash Flow | $629,500 | $378,600 | $214,600 | $-206,600 | $-309,100 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,595,000 | -1,021,200 | -450,000 | -1,038,400 | -324,500 |
| PPE Investments | -44,600 | -31,200 | -13,000 | -83,700 | -59,000 |
| Purchase Of Investment | N/A | 0 | N/A | N/A | -5,600 |
| Sale Of Investment | 964,900 | 649,400 | 435,400 | 799,200 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -12,500 | -12,500 |
| Investing Cash Flow | $-674,700 | $-403,000 | $-27,600 | $-335,400 | $-401,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 800,000 | 800,000 |
| Common Stock Issued | 30,600 | 24,900 | 3,200 | 14,000 | 14,000 |
| Common Stock Repurchased | -3,600 | -3,500 | -3,400 | -2,100 | -2,100 |
| Other Financing Activity | -50,000 | -50,000 | -50,000 | -200,700 | -50,700 |
| Financing Cash Flow | $-23,000 | $-28,600 | $-50,200 | $611,200 | $761,200 |
| Beginning Cash Position | 738,400 | 738,400 | 738,400 | 669,200 | 669,200 |
| End Cash Position | 670,200 | 685,400 | 875,200 | 738,400 | 719,700 |
| Net Cash Flow | $-68,200 | $-53,000 | $136,800 | $69,200 | $50,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 629,500 | 378,600 | 214,600 | -206,600 | -309,100 |
| Capital Expenditure | -47,000 | -31,200 | -13,000 | -83,700 | -59,000 |
| Free Cash Flow | 582,500 | 347,400 | 201,600 | -290,300 | -368,100 |